Acer Therapeutics Inc.
ACERDelisted Nov 20, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001069308
Acer Therapeutics Inc. was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Nov 20, 2023; 30 institutions reported holding it in 13F filings for Q3 2023, worth $3.40M in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Acer Therapeutics Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 30 | 25 | −5 |
| Shares | 1.56M | 1.53M | −36.9K (−2.4%) |
| Value | $4.47M | $3.91M | −$562.1K (−12.6%) |
New holders (2)
Institutions that held Acer Therapeutics Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 36,681 | $94.0K | 0.00% |
| Morgan Stanley | 1 | $0 | 0.00% |
Sold out (7)
Institutions that held Acer Therapeutics Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Two Sigma Advisers, LP | 24,000 | $69.0K |
| Dimensional Fund Advisors LP | 14,665 | $42.0K |
| Millennium Management LLC | 11,451 | $33.0K |
| Tower Research Capital LLC (TRC) | 2,102 | $6.00K |
| Citigroup Inc | 1,000 | $3.00K |
| Bank of America Corp | 52 | $0 |
| Royal Bank of Canada | 100 | $0 |